| Literature DB >> 27899107 |
Zila M Sanchez1, Adriana Sanudo2, Solange Andreoni2, Daniela Schneider3, Ana Paula D Pereira4, Fabrizio Faggiano5.
Abstract
BACKGROUND: Most Brazilian schools do not have a continuous program for drug use prevention and do not conduct culturally adapted activities for that purpose. This study evaluated the impact of the Unplugged program on drug use prevention among children and adolescents in public middle schools of Brazil.Entities:
Keywords: Adolescents; Alcohol; Drugs; Intervention; Prevention; School
Mesh:
Year: 2016 PMID: 27899107 PMCID: PMC5129201 DOI: 10.1186/s12889-016-3877-0
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Fig. 1Flowchart of participation in the two groups in the baseline and follow up, Brazil, 2013
Distribution of the adolescents at the baseline according to sociodemographic variables by study group (n = 3511)
| Baseline | Matched | |||||||
|---|---|---|---|---|---|---|---|---|
| Intervention | Control | Intervention | Control | |||||
| ( | ( | ( | ( | |||||
|
| % |
| % |
| % |
| % | |
| Gender | ||||||||
| Boys | 733 | 48.8 | 957 | 49.1 | 426 | 45.7 | 575 | 46.6 |
| Girls | 768 | 51.2 | 993 | 50.9 | 506 | 54.3 | 659 | 53.4 |
| Years | ||||||||
| 11 – 12 | 480 | 34.4 | 740 | 40.7 | 358 | 40.1 | 478 | 41.5 |
| 13 – 15 | 914 | 65.6 | 1079 | 59.3 | 534 | 59.9 | 673 | 58.5 |
| Grade | ||||||||
| 6th grade | 364 | 23.8 | 507 | 25.6 | 228 | 24.3 | 312 | 25.0 |
| 7th grade | 377 | 24.7 | 607 | 30.6 | 255 | 27.2 | 360 | 28.9 |
| 8th grade | 436 | 28.5 | 578 | 29.2 | 227 | 24.2 | 371 | 29.8 |
| 9th grade | 352 | 23.0 | 290 | 14.6 | 228 | 24.3 | 204 | 16.3 |
| State | ||||||||
| SP | 951 | 68.2 | 1142 | 62.8 | 710 | 75.7 | 847 | 67.9 |
| SC | 443 | 31.8 | 677 | 37.2 | 228 | 24.3 | 400 | 32.1 |
Distribution of past month drug use by age according to group and time point
| 11–12 years | Intervention | Control | Program Effect a | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 4 month follow-up | ORb (95% CI) |
| Baseline | 4 month follow-up | ORb (95% CI) |
| ORa (95% CI) |
| |||||
|
| % |
| % |
| % |
| % | |||||||
| Tobacco | 1/296 | 0.3 | 3/296 | 1.0 | Non-estimable | 0/384 | 0.0 | 0/384 | 0.0 | Non-estimable | Non-estimable | |||
| Alcohol | 19/251 | 7.6 | 19/251 | 7.6 | 1.00 (0.32;3.14) | . > 0.999 | 18/349 | 5.2 | 20/349 | 5.7 | 1.45 (0.43;4.83) | 0.529 | 0.67 (0.12;3.77) | 0.646 |
| Binge drinking | 12/226 | 5.3 | 15/226 | 6.6 | 1.81 (0.51;6.44) | 0.345 | 5/325 | 1.5 | 11/325 | 3.4 | 6.33 (0.91; 43.95 | 0.054 | 0.25 (0.17;1.54) | 0.327 |
| Marihuana | 0/249 | 0.0 | 2/249 | 0.8 | Non-estimable | 1/378 | 0.3 | 4/378 | 1.1 | Non-estimable | Non-estimable | |||
| Inhalants | 2/246 | 0.8 | 4/246 | 1.6 | 2.50 (0.34;18.30) | 0.367 | 1/378 | 0.3 | 5/378 | 1.3 | 6.63 (0.62;70.63) | 0.117 | 0.38 (0.02;7.73) | 0.527 |
| Cocaine | 0/246 | 0.0 | 1/246 | 0.4 | Non-estimable | 0/377 | 0.0 | 0/377 | 0.0 | Non-estimable | Non-estimable | |||
| Crack | 0/246 | 0.0 | 0/246 | 0.0 | Non-estimable | 0/377 | 0.0 | 0/377 | 0.0 | Non-estimable | Non-estimable | |||
| 13–15 years | ||||||||||||||
| Tobacco | 11/441 | 2.5 | 15/441 | 3.4 | 2.10 (0.62;7.20) | 0.235 | 17/547 | 3.1 | 17/547 | 3.1 | 1.00 (0.32;3.11) | >0.99 | 1.45 (0.34;6.25) | 0.615 |
| Alcohol | 59/370 | 15.9 | 71/370 | 19.2 | 1.52 (0.90;2.56) | 0.116 | 80/460 | 17.4 | 88/460 | 19.1 | 1.26 (0.79;2.01) | 0.341 | 1.38 (0.76;2.50) | 0.289 |
| Binge drinking | 40/340 | 11.8 | 38/340 | 11.2 | 0.89 (0.47;1.71) | 0.742 | 45/424 | 10.6 | 63/424 | 14.9 | 2.05 (1.16;3.63) | 0.014 | 0.43 (0.31;1.46) | 0.581 |
| Marihuana | 7/432 | 1.6 | 13/432 | 3.0 | 2.41 (0.79;7.33) | 0.120 | 7/546 | 1.3 | 15/546 | 2.7 | 3.21 (1.00;10.28) | 0.050 | 0.75 (0.16;3.61) | 0.722 |
| Inhalants | 10/430 | 2.3 | 7/430 | 1.6 | 0.61 (0.19;1.91) | 0.393 | 10/540 | 1.9 | 13/540 | 2.4 | 1.46 (0.54;3.96) | 0.455 | 0.41 (0.09;1.91) | 0.259 |
| Cocaine | 0/431 | 0.0 | 5/431 | 1.2 | Non-estimable | 1/544 | 0.2 | 5/544 | 0.9 | 11.96 0.55;259.45) | 0.114 | Non-estimable | ||
| Crack | 0/433 | 0.0 | 6/433 | 1.4 | Non-estimable | 1/545 | 0.2 | 5/545 | 0.9 | 11.49 (0.57;230.50) | 0.111 | Non-estimable | ||
aOR for the multilevel analysis gllamm - intervention x control at 4 month follow-up adjusted for sex and baseline prevalence of drug use
b OR for the multilevel analysis gllamm, 4 month follow up x baseline, in each group (or intervention or control), adjusted by sex
Probabilities of transition between drug use in the past month, considering the changes over time
| 11–12 years | Transition from baseline to follow-up | Intervention | Control | |||||
|---|---|---|---|---|---|---|---|---|
|
| % |
| % | OR | 95%CI |
| ||
| Tobacco | non-use to use | 2/295 | 0.7 | 0/384 | 0.0 | Non-estimable | Non-estimable | Non-estimable |
| use to non-use | 0/1 | 0.0 | 0/0 | 0.0 | ||||
| Alcohol | non-use to use | 8/232 | 3.4 | 7/331 | 2.1 | 1.77 | 0.46;6.83 | 0.409 |
| use to non-use | 8/19 | 42.1 | 5/18 | 27.8 | 2.49 | 0.45;13.73 | 0.296 | |
| Binge drinking | non-use to use | 8/214 | 3.7 | 8/320 | 2.5 | 1.53 | 0.50;4.68 | 0.453 |
| use to non-use | 5/12 | 41.7 | 2/5 | 40.0 | 0.96 | 0.10;9.04 | 0.971 | |
| Marihuana | non-use to use | 2/249 | 0.8 | 4/377 | 1.1 | Non-estimable | Non-estimable | Non-estimable |
| use to non-use | 0/0 | 0.0 | 1/1 | 100.0 | ||||
| Inhalants | non-use to use | 3/244 | 1.2 | 5/377 | 1.3 | Non-estimable | Non-estimable | Non-estimable |
| use to non-use | 1/2 | 50.0 | 1/1 | 100.0 | ||||
| 13–15 years | ||||||||
| Tobacco | non-use to use | 11/430 | 2.6 | 8/530 | 1.5 | 1.70 | 0.68;4.26 | 0.259 |
| use to non-use | 7/11 | 63.6 | 8/17 | 47.1 | 2.02 | 0.42;9.62 | 0.378 | |
| Alcohol | non-use to use | 38/311 | 12.2 | 36/380 | 9.5 | 1.39 | 0.80;2.42 | 0.241 |
| use to non-use | 26/59 | 44.1 | 28/80 | 35.0 | 1.39 | 0.65;2.94 | 0.393 | |
| Binge drinking | non-use to use | 17/300 | 5.7 | 36/379 | 9.5 | 0.57 | 0.31;1.08 | 0.084 |
| use to non-use | 19/40 | 47.5 | 18/45 | 40.0 | 1.28 | 0.53;3.12 | 0.583 | |
| Marihuana | non-use to use | 12/425 | 2.8 | 10/539 | 1.9 | 1.53 | 0.66;3.59 | 0.323 |
| use to non-use | 6/7 | 85.7 | 2/7 | 28.6 | 17.49 | 1.16;63.21 | 0.039 | |
| Inhalants | non-use to use | 5/420 | 1.2 | 9/530 | 1.7 | 0.70 | 0.23;2.11 | 0.528 |
| use to non-use | 8/10 | 80.0 | 6/10 | 60.0 | 2.56 | 0.34;19.18 | 0.358 | |
*cocaine and crack have been excluded from this table because only 1 transition has been observed in the use of each substance